echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Columbotai: The third generation of Claudin 18.2 ADC reported to the clinic

    Columbotai: The third generation of Claudin 18.2 ADC reported to the clinic

    • Last Update: 2021-09-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    introduction

    introduction

    August 26, 2021, the center hosted a four-drug trialbio-pharmaceutical Co.


    (Source: CDE official website)

    SKB315 is a third-generation antibody conjugate drug (ADC) targeting Claudin 18.


    Related reading: Baochuan Bio: CLDN18.


    Kelun is a highly specialized and innovative pharmaceutical group with annual sales revenue of more than 40 billion yuan.


    Sichuan Kelun Botai Bio-Pharmaceutical Co.


    (Product pipeline source: Klus Pharma Inc.


    Reference source:

    Reference source: Reference source:

    [1] CDE official website

    [1] CDE official website

    [2] Kelun official website |Kelun official website |[3] KLUS Pharma | https:// KLUS Pharma | https://

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.